Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/96995
Title: | The search for efficacious new therapies in sepsis needs to embrace heterogeneity |
Authors: | Scicluna, Brendon P. Kenneth Baillie, J. |
Keywords: | Human beings Septicemia -- Diagnosis Steroids -- Analysis |
Issue Date: | 2019 |
Publisher: | American Thoracic Society |
Citation: | Scicluna, B. P., & Baillie, J. K. (2019). The search for efficacious new therapies in sepsis needs to embrace heterogeneity. American Journal of Respiratory and Critical Care Medicine, 199(8), 936-938. |
Abstract: | Most new drug treatments fail because they lack efficacy. In sepsis research, new therapies must contend with an additional barrier: the intractable heterogeneity of the sepsis syndrome. Together, these challenges have so far proved insurmountable. Hundreds of clinical trials have been conducted, at a cost of hundreds of millions of dollars, to test new agents to modulate the host response to injury in sepsis. None have succeeded. The sepsis syndrome itself is simultaneously too broad and too narrow. Sepsis encompasses numerous different etiologies and pathophysiological processes, but—by definition—excludes sterile injuries that lead to the same pathophysiology and organ failures, such as trauma, burns, hemorrhage, and pancreatitis. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/96995 |
Appears in Collections: | Scholarly Works - FacHScABS |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The_search_for_efficacious_new_therapies_in_sepsis_needs_to_embrace_heterogeneity.pdf | 539.03 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.